Chemotherapy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Chemotherapy stocks.

Chemotherapy Stocks Recent News

Date Stock Title
May 8 VNDA Vanda Pharmaceuticals GAAP EPS of -$0.07, revenue of $47.46M
May 8 VNDA Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results
May 8 OPK OPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript
May 8 ICUI ICU Medical, Inc. (NASDAQ:ICUI) Q1 2024 Earnings Call Transcript
May 8 VERU Veru Inc. (VERU) Fiscal 2024 Q2 Earnings: Clinical Advances Amid Financial Strains
May 8 OPK Q1 2024 OPKO Health Inc Earnings Call
May 8 VERU Veru GAAP EPS of -$0.07 misses by $0.01, revenue of $4.14M
May 8 VERU Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program
May 8 OPK Flywire Reports Q1 Loss, Joins ZoomInfo, Inspire Medical Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
May 8 ICUI ICU Medical Inc (ICUI) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with ...
May 8 OPK OPKO Health Inc (OPK) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves Amid ...
May 8 ICUI ICU Medical, Inc. (ICUI) Q1 2024 Earnings Call Transcript
May 8 OPK Opko Health (OPK) Q1 2024 Earnings Call Transcript
May 8 OPK OPKO Health (OPK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
May 8 OPK OPKO Health, Inc. (OPK) Q1 2024 Earnings Call Transcript
May 7 ICUI ICU Medical, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 7 OPK OPKO Health Inc (OPK) Q1 2024 Earnings: Misses Revenue and Earnings Estimates
May 7 ICUI ICU Medical Inc. Reports Mixed Q1 2024 Results, Adjusted EPS Beats Estimates
May 7 ICUI ICU Medical (ICUI) Q1 Earnings and Revenues Surpass Estimates
May 7 OPK OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates
Chemotherapy

Chemotherapy (often abbreviated to chemo and sometimes CTX or CTx) is a type of cancer treatment that uses one or more anti-cancer drugs (chemotherapeutic agents) as part of a standardized chemotherapy regimen. Chemotherapy may be given with a curative intent (which almost always involves combinations of drugs), or it may aim to prolong life or to reduce symptoms (palliative chemotherapy). Chemotherapy is one of the major categories of the medical discipline specifically devoted to pharmacotherapy for cancer, which is called medical oncology.
The term chemotherapy has come to connote non-specific usage of intracellular poisons to inhibit mitosis, cell division. The connotation excludes more selective agents that block extracellular signals (signal transduction). The development of therapies with specific molecular or genetic targets, which inhibit growth-promoting signals from classic endocrine hormones (primarily estrogens for breast cancer and androgens for prostate cancer) are now called hormonal therapies. By contrast, other inhibitions of growth-signals like those associated with receptor tyrosine kinases are referred to as targeted therapy.
Importantly, the use of drugs (whether chemotherapy, hormonal therapy or targeted therapy) constitutes systemic therapy for cancer in that they are introduced into the blood stream and are therefore in principle able to address cancer at any anatomic location in the body. Systemic therapy is often used in conjunction with other modalities that constitute local therapy (i.e. treatments whose efficacy is confined to the anatomic area where they are applied) for cancer such as radiation therapy, surgery or hyperthermia therapy.
Traditional chemotherapeutic agents are cytotoxic by means of interfering with cell division (mitosis) but cancer cells vary widely in their susceptibility to these agents. To a large extent, chemotherapy can be thought of as a way to damage or stress cells, which may then lead to cell death if apoptosis is initiated. Many of the side effects of chemotherapy can be traced to damage to normal cells that divide rapidly and are thus sensitive to anti-mitotic drugs: cells in the bone marrow, digestive tract and hair follicles. This results in the most common side-effects of chemotherapy: myelosuppression (decreased production of blood cells, hence also immunosuppression), mucositis (inflammation of the lining of the digestive tract), and alopecia (hair loss). Because of the effect on immune cells (especially lymphocytes), chemotherapy drugs often find use in a host of diseases that result from harmful overactivity of the immune system against self (so-called autoimmunity). These include rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, vasculitis and many others.

Browse All Tags